Saturday, July 4, 2026

LAUNCH IMMINENT: Kim Jong Un Prepares To Fire 9,300-Mile ICBM That Can NUKE Any City in the US

North Korea's recent engine tests at Dongchang-ri hint at a possible imminent launch of the new ICBM Hwasong-20, capable of striking the U.S.

Lineage2M Goes Big in Southeast Asia with May 20 Launch

NCSOFT will launch Lineage2M in six Southeast Asian countries on May 20, featuring localization and cross-region play.

Kim Jong Un Heads to Beijing as China, Russia, and North Korea Tighten Their Alliance

Kim Jong Un's visit to China for the Victory Day celebration aims to strengthen ties with China and Russia, promoting a new international order.

Tag: Cenobamate

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How SK Life Science is Bridging Communication Gaps in Epilepsy Management

SK Life Science will present findings on epilepsy treatment and patient-provider communication at the 2026 AAN Annual Meeting in Chicago.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.